A St. Norbert College basketball team honors Hadley Baker, a 12-year-old who died from cancer, with a tribute game on Feb. 22 ...

Improved diagnostics and treatments mean that the survival rate for children with cancer continues to increase, the ...

Major Finding: An analysis of immune responses in children with cancer reveals the effects of age and tumor type. Concept: Pediatric tumors have varied mutational burden which correlates with immune ...

Leveraging its early childhood expertise, Avathon invests in Yellow Brick Road, a founder-owned, center-based platform in the Midwest Founded in 2006 as a single-center business, Yellow Brick Road ...

CLEVELAND — Cleveland Clinic is recognized as one of the nation's top hospitals for treating pediatric cancer, yet experts say research and treatment for children with cancer face significant ...

Last March, then 6 year old Nora, was diagnosed with DIPG, an aggressive and inoperable form of childhood brain cancer. “In 2024, that is a real hard pill to swallow when you hear your ...

Now is the perfect time to not only spread awareness but also show that you stand in solidarity with those affected by cancer. One easy way to do that is through wearing ribbons. The iconic pink ...

But much of that carefree life has been taken away from the Atlanta girl by a rare form of cancer called Ewing sarcoma, a battle she has fought for the past two years. "I can't do a lot of that ...

Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 ...

A new targeted therapy, CT-179, shows promise in treating childhood brain cancers like medulloblastoma by effectively targeting cancer stem cells responsible for recurrence and therapy resistance.

Day One Biopharma's OJEMDA received FDA accelerated approval in 2024 for relapsed/refractory BRAF-altered pediatric low-grade glioma, with strong Phase 2 trial results and ongoing Phase 3 studies.